Welgus Howard G. bought ARQT

August 1, 2025 · Form 4 insider transaction

Welgus Howard G. bought 6,110 shares of Arcutis Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Acquired (buy-side)
Shares
6,110
Price
$0.00
Total value
N/A
Role
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 1, 2025
Filing dateAugust 5, 2025
Shares owned after106,316
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026.

View the original Form 4 on SEC EDGAR